Haihai Liang
- Molecular Biology top 5%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Epidemiology top 10%
- Topics
- Cancer-related molecular mechanisms research (28 papers)MicroRNA in disease regulation (23 papers)Cardiac Fibrosis and Remodeling (15 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsThe FASEB Journal
- Partner nations
- ChinaMacaoSwitzerland
In The Last Decade
Haihai Liang
100 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 2.3k
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 533
- Cardiology and Cardiovascular Medicine 486
- Epidemiology 280
Countries citing papers authored by Haihai Liang
This map shows the geographic impact of Haihai Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haihai Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haihai Liang more than expected).
Fields of papers citing papers by Haihai Liang
This network shows the impact of papers produced by Haihai Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haihai Liang. The network helps show where Haihai Liang may publish in the future.
Co-authorship network of co-authors of Haihai Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Haihai Liang. A scholar is included among the top collaborators of Haihai Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haihai Liang. Haihai Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 19 | |
| 6 | 16 | |
| 7 | 6 | |
| 8 | 7 | |
| 9 | 9 | |
| 10 | 42 | |
| 11 | 10 | |
| 12 | 1 | |
| 13 | Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer | 1 |
| 14 | 45 | |
| 15 | 14 | |
| 16 | 21 | |
| 17 | 99 | |
| 18 | 22 | |
| 19 | 20 | |
| 20 | 74 |
About Haihai Liang
Haihai Liang is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 108 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (28 papers), MicroRNA in disease regulation (23 papers) and Cardiac Fibrosis and Remodeling (15 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.3k citations) and Cardiology and Cardiovascular Medicine (486 citations). Haihai Liang has collaborated with scholars based in China, Macao and Switzerland. Frequent co-authors include Hongli Shan, Yanjie Lu, Xiaoguang Zhao, Xuelian Li, Baofeng Yang, Yunyan Gu, Huitong Shan, Chaoqian Xu, Jian Sun and Rui Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.